Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Histopathological diagnosis, treatments, and outcomes

From: Angiomatoid fibrous histiocytoma: a series of seven cases including genetically confirmed aggressive cases and a literature review

Case No Diagnosis of NB Diagnosis of EB Additional treatment EWSR1 rearrangement Recurrence / Metastasis Outcome Follow-up (mo.)
1 NA AFH WE NA −/− CDF 10
2 NA myxoid liposarcoma ray amputation + −/− CDF 5
3 Ewing sarcoma NA Chemo + WE +# + / + NED 18
4 spindle cell tumor NA WE + −/− CDF 57
5 myxofibrosarcoma NA WE + −/− CDF 61
6 NA synovial sarcoma Chemo + WE +# + / + DOD 55
7 NA AFH observation NA −/− CDF 40
  1. NB needle biopsy, EB excisional biopsy, ME marginal excision, WE wide excision, CDF continuous disease free, NED no evidence of disease, DOD died of disease, NA not applicable. #. CREB1 rearrangement was also demonstrated by FISH, using custom CREB1 break-apart probe set (GSP laboratory, Kobe, Japan)